Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine

Manuela Giachelia; Francesco D'Alò; Emiliano Fabiani; Nathalie Saulnier; Annalisa Di Ruscio; Francesco Guidi; Stefan Hohaus; Maria Teresa Voso; Giuseppe Leone

doi:10.1016/j.leukres.2010.07.022

Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine

Manuela Giachelia
, Francesco D'Alò
, Emiliano Fabiani
, Nathalie Saulnier
, Annalisa Di Ruscio
, Francesco Guidi
, Stefan Hohaus
, Maria Teresa Voso
, Giuseppe Leone

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Abstract

Abnormal gene promoter methylation contributes to deregulate gene expression of hematopoietic progenitors in myelodysplastic syndromes (MDS). We analyzed the gene expression profile of myelodysplastic and normal CD34+ hematopoietic stem cells (HSCs) treated in vitro with decitabine. We identified a list of candidate tumor suppressor genes, expressed at low levels in MDS HSCs and induced by hypomethylating treatment only in MDS, but not in normal HSCs. Real-time RT-PCR confirmed reduced CD9 expression in MDS CD34+ and bone marrow mononuclear cells, compared to normal controls. CD9 was specifically up-regulated by decitabine treatment in myelodysplastic CD34+ cells.

Lingua originale	Inglese
pagine (da-a)	465-471
Numero di pagine	7
Rivista	Leukemia Research
Volume	35
Numero di pubblicazione	4
DOI	https://doi.org/10.1016/j.leukres.2010.07.022
Stato di pubblicazione	Pubblicato - apr 2011
Pubblicato esternamente	Sì

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

Accesso al documento

10.1016/j.leukres.2010.07.022

Altri file e collegamenti

Link to publication in Scopus

Cita questo

@article{8c3936e7bfaa4b88bb43326424a4b8e4,

title = "Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine",

abstract = "Abnormal gene promoter methylation contributes to deregulate gene expression of hematopoietic progenitors in myelodysplastic syndromes (MDS). We analyzed the gene expression profile of myelodysplastic and normal CD34+ hematopoietic stem cells (HSCs) treated in vitro with decitabine. We identified a list of candidate tumor suppressor genes, expressed at low levels in MDS HSCs and induced by hypomethylating treatment only in MDS, but not in normal HSCs. Real-time RT-PCR confirmed reduced CD9 expression in MDS CD34+ and bone marrow mononuclear cells, compared to normal controls. CD9 was specifically up-regulated by decitabine treatment in myelodysplastic CD34+ cells.",

keywords = "CD9, Gene expression profiling, Hematopoietic stem cell, Hypomethylating agents, Myelodysplastic syndromes",

author = "Manuela Giachelia and Francesco D'Al{\`o} and Emiliano Fabiani and Nathalie Saulnier and \{Di Ruscio\}, Annalisa and Francesco Guidi and Stefan Hohaus and Voso, \{Maria Teresa\} and Giuseppe Leone",

note = "Funding Information: Authors would like to thank Dr. Pierluigi Puggioni for flow cytometry analysis and all physicians from the Department of Hematology of Universit{\`a} Cattolica del Sacro Cuore in Rome, for their indirect contribution to this work. This work was supported by Fondazione Roma “Progetto cellule staminali, Una nuova frontiera nella ricerca biomedica”. This sponsor had no involvement in the study design, in the collection, analysis and interpretation of data, in the writing of the manuscript, and in the decision to submit the manuscript for publication. ",

year = "2011",

month = apr,

doi = "10.1016/j.leukres.2010.07.022",

language = "English",

volume = "35",

pages = "465--471",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Ltd.",

number = "4",

}

TY - JOUR

T1 - Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine

AU - Giachelia, Manuela

AU - D'Alò, Francesco

AU - Fabiani, Emiliano

AU - Saulnier, Nathalie

AU - Di Ruscio, Annalisa

AU - Guidi, Francesco

AU - Hohaus, Stefan

AU - Voso, Maria Teresa

AU - Leone, Giuseppe

N1 - Funding Information: Authors would like to thank Dr. Pierluigi Puggioni for flow cytometry analysis and all physicians from the Department of Hematology of Università Cattolica del Sacro Cuore in Rome, for their indirect contribution to this work. This work was supported by Fondazione Roma “Progetto cellule staminali, Una nuova frontiera nella ricerca biomedica”. This sponsor had no involvement in the study design, in the collection, analysis and interpretation of data, in the writing of the manuscript, and in the decision to submit the manuscript for publication.

PY - 2011/4

Y1 - 2011/4

N2 - Abnormal gene promoter methylation contributes to deregulate gene expression of hematopoietic progenitors in myelodysplastic syndromes (MDS). We analyzed the gene expression profile of myelodysplastic and normal CD34+ hematopoietic stem cells (HSCs) treated in vitro with decitabine. We identified a list of candidate tumor suppressor genes, expressed at low levels in MDS HSCs and induced by hypomethylating treatment only in MDS, but not in normal HSCs. Real-time RT-PCR confirmed reduced CD9 expression in MDS CD34+ and bone marrow mononuclear cells, compared to normal controls. CD9 was specifically up-regulated by decitabine treatment in myelodysplastic CD34+ cells.

AB - Abnormal gene promoter methylation contributes to deregulate gene expression of hematopoietic progenitors in myelodysplastic syndromes (MDS). We analyzed the gene expression profile of myelodysplastic and normal CD34+ hematopoietic stem cells (HSCs) treated in vitro with decitabine. We identified a list of candidate tumor suppressor genes, expressed at low levels in MDS HSCs and induced by hypomethylating treatment only in MDS, but not in normal HSCs. Real-time RT-PCR confirmed reduced CD9 expression in MDS CD34+ and bone marrow mononuclear cells, compared to normal controls. CD9 was specifically up-regulated by decitabine treatment in myelodysplastic CD34+ cells.

KW - CD9

KW - Gene expression profiling

KW - Hematopoietic stem cell

KW - Hypomethylating agents

KW - Myelodysplastic syndromes

UR - https://www.scopus.com/pages/publications/79952359985

U2 - 10.1016/j.leukres.2010.07.022

DO - 10.1016/j.leukres.2010.07.022

M3 - Article

SN - 0145-2126

VL - 35

SP - 465

EP - 471

JO - Leukemia Research

JF - Leukemia Research

IS - 4

ER -

Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine

Abstract

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo